Pharmaxis Research Programs Highlighted At European Respiratory Society Congress
Oct 3rd 2008Drug InformationRespiratory
Pharmaceutical company Pharmaxis (ASX: PXS, NASDAQ: PXSL) has announced that researchers will present 12 abstracts from its respiratory disease program at the 2008 European Respiratory Society Congress (ERS) being held in Berlin from the 4th to the 8th October. The ERS brings together many of the world’s top respiratory researchers and clinicians to hear latest advances in clinical diagnosis and treatment.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
